GREY:DGCRF - Post by User
Post by
CUR2004on Jun 09, 2011 8:59pm
222 Views
Post# 18696564
New study
New studyThe “New” Prostate Cancer InfoLink would note, however, that the proposed algorithm still tells us nothing about the ability to differentiate between clinically significant and clinically indolent forms of prostate cancer. The value of the proposed algorithm at this time is restricted to the elimination of unnecessary biopsies. This is a worthy goal in itself, but only addresses part of the problem. In addition, the proposed algorithm clearly needs to be tested prospectively as opposed to retrospectively before it could be applied to clinical decision making on an ongoing basis.me/low grade cancer.